Further, IHC of tissue samples suggested that in BRAF mutated colon samples, expression levels of BST2, CALB2, and ENO2 are significantly higher than those in BRAF wild-type tumor samples, as shown in Figures 6A–F, respectively. This evidence concerns the gene BST2 and neoplasm.